Lupin developing new drugs to treat cancer, metabolic disorders

14 Jan 2019 Evaluate

Lupin is developing a pipeline of products under its new drug discovery programme to treat various diseases like cancer and metabolic disorders. The Novel Drug Discovery and Development (NDDD) is focused and committed on developing a pipeline of highly differentiated and innovative new chemical entities in various therapeutic areas like oncology, immunology and metabolic disorders.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2179.70 -10.80 (-0.49%)
09-Jan-2026 14:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.10
Dr. Reddys Lab 1205.40
Cipla 1463.00
Zydus Lifesciences 892.05
Lupin 2179.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×